Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anti-inflammatory cytokines are soluble protein messengers secreted by immune and non-immune cells that regulate the immune response by opposing the actions of pro-inflammatory cytokines. These cytokines—including interleukin-10 (IL-10), interleukin-4 (IL-4), interleukin-13 (IL-13), interleukin-1 receptor antagonist, IL-11, and to some extent IL-6—act by suppressing inflammation, promoting tissue repair, and restoring immune homeostasis. They help prevent excessive or chronic inflammation that can result in tissue damage or autoimmune disease, but excessive anti-inflammatory activity may compromise effective host defense. Therapeutically, their modulation (by recombinant proteins, gene therapy, or drugs affecting their production or signaling) is being explored for diseases characterized by overactive immune responses, chronic pain, asthma, and inflammatory disorders.
Ligand binding to cytokine receptors (stimulates anti-inflammatory pathways); Blockade of pro-inflammatory cytokine signaling (via antagonists or receptor decoys); Inhibition of immune cell activation and migration.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune response modulation via secretion of anti-inflammatory cytokines.